Table of Contents Author Guidelines Submit a Manuscript
Volume 2014 (2014), Article ID 862925, 7 pages
Review Article

Oncolytic Immunotherapy: Where Are We Clinically?

1Cancer Gene Therapy Group, Haartman Institute, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland
2TILT Biotherapeutics Ltd., P. Hesperiankatu 37A22, 00260 Helsinki, Finland

Received 6 November 2013; Accepted 16 December 2013; Published 16 January 2014

Academic Editors: H. J. Haisma and H. Hofler

Copyright © 2014 Akseli Hemminki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Akseli Hemminki, “Oncolytic Immunotherapy: Where Are We Clinically?,” Scientifica, vol. 2014, Article ID 862925, 7 pages, 2014. doi:10.1155/2014/862925